SPECIAL: Dissecting the melanoma ecosystem one cell at the time during immunotherapy
The aim of this study was to identify potential biomarkers of response to immunotherapy (anti-PD1-based) as well as gain understanding of the biological mechanism of therapy resistance (either intrinsic or acquired) in melanoma patients. Single cell RNA sequencing was performed from pre- and on-treatment (2-3 weeks after immunotherapy) metastatic biopsies from stage III and IV melanoma patients.
- Type: Other
- Archiver: European Genome-Phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Dataset ID | Description | Technology | Samples |
---|---|---|---|
EGAD00001009291 | unspecified | 46 | |
EGAD00001010921 | unspecified | 6 |
Publications | Citations |
---|---|
CD4<sup>+</sup> T cell-induced inflammatory cell death controls immune-evasive tumours.
Nature 618: 2023 1033-1040 |
61 |
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity.
Cancer Cell 41: 2023 1207-1221.e12 |
18 |
STmut: a framework for visualizing somatic alterations in spatial transcriptomics data of cancer.
Genome Biol 24: 2023 273 |
3 |
ALDH1A3-acetaldehyde metabolism potentiates transcriptional heterogeneity in melanoma.
Cell Rep 43: 2024 114406 |
2 |